Job Opportunity – Senior Project Mantager at C-Path

Critical Path Institute is a large multi-disciplinary scientific non-profit organization focused on accelerating the development of new therapies. CAMD is dedicated to Alzheimer’s and Parkinson’s disease.  The Senior Project Manager works in close partnership with the CAMD Executive Director to provide operational and project management excellence for C-Path and affiliates’ virtual working groups to advance drug development tools and therapies to treat brain diseases. Additionally, the Sr. Project Manager will be responsible for ensuring that the Parkinson’s team meets the requirements of the grants which fund this work.Continue reading

Insys Therapeutics Receives FDA Orphan Drug Designation for Its Liposomal Encapsulated Paclitaxel for the Treatment of Ovarian Cancer

Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery systems, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to its Liposomal Encapsulated Paclitaxel (LEP) candidate for the treatment of ovarian cancer.Continue reading

Mission3 is now arivis

Phoenix, AZ – January 20, 2015 – Mission3, a leading provider of cloud-based and enterprise regulatory information management, clinical trial master file, and promotional materials management solutions for the life sciences industry, is changing its name to arivis in coordination with its parent company arivis, AG. arivis will combine Mission3’s cloud-based Clireo product and regulatory services as well as its enterprise GlobalTrack regulatory information management (RIM) product with arivis AG’s high-resolution, 3D+ image management solution to provide a high-value portfolio of solutions for life science, academic research, and healthcare clients.

Continue reading